Novavax (NVAX) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.33 -0.74%
EPS Growth %: -164.5%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -164.5%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $5.680 million versus the consensus estimate of $6.17 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
